Clinical Trial Update: A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

View source ↗

Summary

This entry describes a prospective clinical trial evaluating low-dose decitabine combined with the COP chemotherapy regimen for relapsed and refractory diffuse …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Decitabine (Decitabine)
• Doxorubicin (doxorubicin)
• PREDNISONE (Prednisone)
• Vincristine (vincristine)

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Lymphoma | Status: RECRUITING